![](/img/cover-not-exists.png)
P-959 A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC)
Liao, Z., Komaki, R., Milas, L., Chen, Y., Kies, M., Chang, J., Jeter, M., Guerrero, T., Blumenschein, G., Cox, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81452-7
Date:
July, 2005
File:
PDF, 147 KB
english, 2005